These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 30341861)
41. The Effect of Sirichaiwetchakoon K; Churproong S; Kupittayanant S; Eumkeb G J Altern Complement Med; 2021 Aug; 27(8):669-677. PubMed ID: 34076495 [No Abstract] [Full Text] [Related]
42. Dyslipidemia and reduced total antioxidant status in young adult Saudis with prediabetes. Mohieldein AH; Hasan M; Al-Harbi KK; Alodailah SS; Azahrani RM; Al-Mushawwah SA Diabetes Metab Syndr; 2015; 9(4):287-91. PubMed ID: 25470641 [TBL] [Abstract][Full Text] [Related]
43. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus. Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE; Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207 [TBL] [Abstract][Full Text] [Related]
44. Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China. Lu Y; Zhang H; Lu J; Ding Q; Li X; Wang X; Sun D; Tan L; Mu L; Liu J; Feng F; Yang H; Zhao H; Schulz WL; Krumholz HM; Pan X; Li J; JAMA Netw Open; 2021 Sep; 4(9):e2127573. PubMed ID: 34586366 [TBL] [Abstract][Full Text] [Related]
45. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study. Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176 [TBL] [Abstract][Full Text] [Related]
46. Factors Associated with Poor Glycemic and Lipid Levels in Ambulatory Diabetes Mellitus Type 2 Patients in Asmara, Eritrea: A Cross-Sectional Study. Achila OO; Ghebretinsae M; Kidane A; Simon M; Makonen S; Rezene Y J Diabetes Res; 2020; 2020():5901569. PubMed ID: 32090121 [TBL] [Abstract][Full Text] [Related]
47. The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease. Kumar DP; Caffrey R; Marioneaux J; Santhekadur PK; Bhat M; Alonso C; Koduru SV; Philip B; Jain MR; Giri SR; Bedossa P; Sanyal AJ Sci Rep; 2020 Jun; 10(1):9330. PubMed ID: 32518275 [TBL] [Abstract][Full Text] [Related]
48. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients. Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505 [TBL] [Abstract][Full Text] [Related]
49. Impact of Blood Lipids on 10-Year Cardiovascular Risk in Individuals Without Dyslipidemia and With Low Risk Factor Burden. Zhou Z; Ong KL; Whelton SP; Allison MA; Curtis AJ; Blaha MJ; Breslin M; Tonkin A; Magnussen CG; Budoff M; Nelson MR Mayo Clin Proc; 2022 Oct; 97(10):1883-1893. PubMed ID: 35760597 [TBL] [Abstract][Full Text] [Related]
50. Clinical Case Series of Decrease in Shear Wave Elastography Values in Ten Diabetic Dyslipidemia Patients Having NAFLD with Saroglitazar 4 mg: An Indian Experience. Roy S Case Rep Med; 2020; 2020():4287075. PubMed ID: 32280349 [TBL] [Abstract][Full Text] [Related]
51. The effect of dual PPAR alpha/gamma stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients. Seber S; Ucak S; Basat O; Altuntas Y Diabetes Res Clin Pract; 2006 Jan; 71(1):52-8. PubMed ID: 16009445 [TBL] [Abstract][Full Text] [Related]
52. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease. Pennell P; Leclercq B; Delahunty MI; Walters BA Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163 [TBL] [Abstract][Full Text] [Related]
53. Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial. Ihm SH; Chung WB; Lee JM; Hwang BH; Yoo KD; Her SH; Song WH; Chae IH; Park TH; Kim JH; Jeon DW; Cho BR; Kang SH; Park SD; Lee JB; Woo JT; Lee BW; Han KA; Won KH; Kim HS; Yu JM; Chung CH; Kim HJ; Cho HC; Seung KB Clin Ther; 2020 Oct; 42(10):2021-2035.e3. PubMed ID: 32891418 [TBL] [Abstract][Full Text] [Related]
54. The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population. Yang P; Hu W; Fu Z; Sun L; Zhou Y; Gong Y; Yang T; Zhou H Lipids Health Dis; 2016 Jul; 15():120. PubMed ID: 27457614 [TBL] [Abstract][Full Text] [Related]
55. [La educación multimedia como apoyo en el manejo de pacientes con diabetes tipo 2. Estudio cuasi experimental]. Aguila IP; Velázquez-López L; Goycochea-Robles MAV; Angulo-Angulo F; Peña JE Cir Cir; 2018; 86(5):404-411. PubMed ID: 30226499 [TBL] [Abstract][Full Text] [Related]
56. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin. Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021 [TBL] [Abstract][Full Text] [Related]
57. The beneficial effect of soybean (Glycine max (L.) Merr.) leaf extracts in adults with prediabetes: a randomized placebo controlled trial. Choi MS; Ryu R; Seo YR; Jeong TS; Shin DH; Park YB; Kim SR; Jung UJ Food Funct; 2014 Jul; 5(7):1621-30. PubMed ID: 24873894 [TBL] [Abstract][Full Text] [Related]
58. Mate tea (Ilex paraguariensis) improves glycemic and lipid profiles of type 2 diabetes and pre-diabetes individuals: a pilot study. Klein GA; Stefanuto A; Boaventura BC; de Morais EC; Cavalcante Lda S; de Andrade F; Wazlawik E; Di Pietro PF; Maraschin M; da Silva EL J Am Coll Nutr; 2011 Oct; 30(5):320-32. PubMed ID: 22081618 [TBL] [Abstract][Full Text] [Related]
59. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension. Geva M; Shlomai G; Berkovich A; Maor E; Leibowitz A; Tenenbaum A; Grossman E Cardiovasc Diabetol; 2019 Apr; 18(1):53. PubMed ID: 31029146 [TBL] [Abstract][Full Text] [Related]
60. Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia. Ose L; Budinski D; Hounslow N; Arneson V Atherosclerosis; 2010 May; 210(1):202-8. PubMed ID: 20080236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]